Investment
Features
FeesSafety
Academy
More
Pluang+

Compare United States Brent Oil Fund LP (BNO) vs Eli Lilly And Co (LLY) Price & Performance

United States Brent Oil Fund LPTrade
Eli Lilly And CoTrade

Price performance (Past 24H)

Key statistics

United States Brent Oil Fund LP vs Eli Lilly And Co — how do they compare? United States Brent Oil Fund LP trades at $50.89, while Eli Lilly And Co trades at $1,218.5 (market cap $1.08T). The key difference: Eli Lilly And Co pays a 0.57% dividend while United States Brent Oil Fund LP pays none. Which is the better fit depends on your goals.

BNOLLY
Sector
Commodities - EnergyHealth
52-Week High
$60.13$1.24K
52-Week Low
$27.20$639.43
Market Cap
$1.08T
Enterprise Value
$1.13T
Dividend Yield
0.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

United States Brent Oil Fund LP

BNO is trading at $50.505, up 0.79% with a bullish technical outlook supported by moving averages. The oil market faces significant supply disruptions from Middle East tensions, particularly the Strait of Hormuz closure, creating volatility. Recent OPEC demand forecast cuts contrast with supply constraints, creating a complex fundamental backdrop for oil-related securities.

The stock presents opportunity from ongoing supply constraints but faces headwinds from demand destruction and inventory builds. Key risks include geopolitical resolution and demand volatility. Technical momentum remains positive near-term, but fundamental uncertainties require careful monitoring of oil market developments.

Eli Lilly And Co

Eli Lilly (LLY) trades at $1,231.58, up 3.87% in the past 24 hours, reflecting strong momentum near its 52-week high. The stock exhibits bullish technical signals with robust fundamentals, including 48% revenue growth in Q2 2026 and a net income margin of 33.53%. Recent news highlights legal actions against black-market drug sales and positive analyst sentiment following earnings beats.

Outlook remains positive with a consensus price target of $1,380, though high valuation ratios (P/E 40.79) and regulatory risks pose challenges. Earnings growth and pipeline advancements, like retatrutide, drive upside potential, but investors should monitor competitive pressures and execution risks.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About United States Brent Oil Fund LP

BNO is a commodity ETF that tracks the daily price of Brent crude oil futures. It provides exposure to the international oil benchmark, which often trades at a premium to the U.S. WTI benchmark, and is primarily used for short-term trading due to roll costs.

Read more on BNO

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Read more on LLY